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AbstrACt
Objectives To conduct a UK-wide survey of young people 
who have experienced cancer, carers and professionals, 
to identify and prioritise research questions to inform 
decisions of research funders and support the case for 
research with this unique cancer population.
Design James Lind Alliance Priority Setting Partnership.
setting UK health service and community.
Methods A steering group oversaw the initiative and 
partner organisations were recruited. Unanswered 
questions were collected in an online survey. Evidence 
searching veriied uncertainties. An interim survey was 
used to rank questions prior to a inal prioritisation 
workshop.
Participants Young people aged 13–24 years with 
a current or previous cancer diagnosis, their families, 
friends, partners and professionals who work with this 
population.
results Two hundred and ninety-two respondents 
submitted 855 potential questions. Following a reining 
process and removal of ‘out of scope’ questions, 208 
unique questions remained. Systematic evidence checking 
identiied seven answered questions and 16 were the 
subject of ongoing studies. The interim survey was 
completed by 174 participants. The top 30 questions were 
prioritised at a workshop attended by 25 young people, 
parents and multidisciplinary professionals. The top three 
priorities are: (1) What psychological support package 
improves psychological well-being, social functioning 
and mental health during and after treatment? (2) What 
interventions, including self-care, can reduce or reverse 
adverse short-term and long-term effects of cancer 
treatment? (3) What are the best strategies to improve 
access to clinical trials? The remaining questions relect 
the complete cancer pathway: new therapies, life after 
cancer, support, education/employment, relapse and end-
of-life care.
Conclusions We have identiied shared research priorities 
for young people with cancer using a rigorous, person-
centred approach involving stakeholders typically not 
involved in setting the research agenda. The breadth of 
priorities suggest future research should focus on holistic 
and psychosocial care delivery as well as traditional drug/
biology research.
IntrODuCtIOn
Young people, broadly those aged 13–24 years 
at diagnosis, present with a spectrum of cancers 
distinct from children and older adults.1 The 
treatment and care they receive is complex, a 
consequence of a disparate range of cancer 
types occurring during a period of unique 
physical and psychological growth, superim-
posed on the social and cultural dimensions 
of teenage and young adult development. 
This is further complicated by an extensive 
network of significant others, such as parents, 
siblings, partners and peers. In the UK, young 
people account for approximately 2600 new 
cancer cases every year, representing less than 
1% of all new cancers; despite this, cancer is 
the leading cause of disease death in young 
people aged 15–24 years.2 
strengths and limitations of this study
 Ź Stakeholders who do not often have a say in setting 
the research agenda were invited to submit research 
questions and prioritise them via online surveys.
 Ź Young people, carers and clinicians agreed on the 
top 10 priority topics.
 Ź We made use of the well-established and transpar-
ent James Lind Alliance methodology and provide 
clarity in our description of decision making in the 
inal top 10 Prioritisation workshop.
 Ź There was under-representation from minority eth-
nic groups and males.
 Ź We are unable to determine the response rate 
of the survey due to the snowballing method of 
recruitment.
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There are additional factors to be considered. We 
already know young people’s physical, psychological and 
social responses to a cancer diagnosis are different. For 
some cancers they have poorer survival than older adults 
and children, while other cancers demonstrate better 
outcomes.3–5 Where poorer outcomes are reported, 
routes to diagnosis, unique host and cancer biology, 
responses to adult/child protocols and lesser involve-
ment in cancer research are all factors that have been 
implicated.6–10 We also know that caring for young people 
is complex; age-appropriate care has now been defined,11 
and this will help services to meet the distinct needs of 
this population.
The research agenda for young people with cancer 
has typically been set by professionals and researchers 
(http:// csg. ncri. org. uk/ about- the- csgs/ clinical- studies- 
groups/ tya- germ- cell- tumours/). In the UK, young 
people have prioritised research themes identified by 
professionals.12 13 However, working with young people 
and carers/significant others as equal partners to set 
research priorities for young people with cancer had not 
yet been explored. Prioritising areas for research as iden-
tified by young people and carers is crucial as increasing 
evidence illustrates research questions and outcomes 
prioritised by professionals may not be aligned to those 
experiencing the disease.14 Patients and carers tend to 
prioritise non-drug treatment research while ongoing 
research strategies are dominated by drug evaluations.15 
This mismatch in priorities is particularly relevant for 
young people due to their unique psychosocial status and 
rarity of cancer types experienced. Furthermore, research 
funders increasingly ask if proposed areas of research are 
a priority area for patients as well as professionals.
The James Lind Alliance (JLA) bring together patients, 
carers and clinicians in Priority Setting Partnerships 
(PSPs) to identify and prioritise unanswered questions 
(uncertainties) in specific health conditions (http://
www. jla. nihr. ac. uk). The purpose is to inform funders 
of priority issues important to patients, carers and clini-
cians (http://www. jla. nihr. ac. uk/ priority- setting- partner-
ships/). Initially, PSPs focused on ‘treatment’ related 
uncertainties. However, ‘treatments’ are now interpreted 
more broadly and can include causes, diagnosis, prog-
nosis, care, support and survivorship.16
Following the JLA methodology, we aimed to conduct 
a UK-wide prioritisation exercise for cancer in young 
people. Our ultimate aim was to identify and priori-
tise research questions to inform decisions of research 
funders and support the case for research in this under-
served group.
MethODs
Methodology was in concordance with the JLA process16: 
the full protocol is available from: http://www. jla. nihr. 
ac. uk/ priority- setting- partnerships/ teenage- and- young- 
adult- cancer/. Briefly, this involved forming a steering 
group to define the scope and oversee progress, then 
seeking questions of relevance, finding which were unan-
swered, and prioritising these through online ranking to 
short-list questions to be finally prioritised in an all day, 
in-person workshop with key stakeholders.
ethical considerations
Ethical approvals are not required for JLA partnerships 
as per JLA and National Health Services Patient Safety 
Agency National Research Ethics Service guidance.17
set-up
Steering group
An expert steering group comprising all co-authors 
oversaw the project, approved aims/objectives, survey 
materials, cleaned data and provided expert opinions for 
evidence checking. The JLA chair (SU) provided neutral 
facilitation ensuring all voices were heard. The group 
included young people with a previous cancer diagnosis 
(n=5), healthcare and allied health professionals with a 
minimum of 50% patient facing role: nursing, n=2; youth 
support co-ordinator, n=1; adult medical oncology, n=1; 
adult clinical oncology, n=1; paediatric haematology, 
n=1; psychiatry, n=1; general practitioner, n=1, paediatric 
oncology, n=1. Two funding partners were members but 
not involved in the final prioritisation exercise, nor were 
non-clinical researchers (SA, LF, FG). The steering group 
identified potential partners mainly charities, profes-
sional and young person networks who were approached 
to assist with survey dissemination ensuring wide reach of 
the survey.
The scope
Cancer care for young people is complex, therefore the 
scope was kept broad and included questions on preven-
tion, causes, diagnosis, treatment, care, follow-up, survi-
vorship, relapse and end-of-life (figure 1).
Our aim was, ‘To identify gaps and unanswered ques-
tions in research, the answers to which may reduce the 
individual and societal burden of young peoples’ cancer.’
Process
A summary of the complete JLA process can be seen in 
figure 2.
Stage 1: collecting questions
The survey was developed by the steering group and 
piloted with five young people, nine parents and five 
professionals outside the steering group. The survey was 
launched on 4 October 2016 and remained open until 31 
December 2016. The following groups could participate:
 Ź Anyone diagnosed with cancer between 13–24 years.
 Ź Relatives/friends/partners/carers of someone with a 
cancer diagnosis between 13–24 years.
 Ź Professionals working with young people aged 
13–24 years with cancer.
Respondents could submit up to five questions related 
to young people’s cancer they considered unanswered. 
Basic demographic data were requested and a box was 
available for free text comments. Our partners promoted 
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the survey through websites, social media, newsletters and 
conferences including a young person’s cancer confer-
ence. After 3 weeks, an interim analysis of demographic 
details identified under-represented groups and strategies 
were employed to promote the survey to those groups.
Stage 2: reining questions
Submitted questions were examined in detail and free 
text sections studied for further questions.
Organising the questions
Questions were coded by LF, SA and FG using the Inter-
national Cancer Research Partnership Common Scien-
tific Outline (CSO, https://www. icrpartnership. org/ cso) 
to group questions into themes easing review and discus-
sion. Differences in opinion in coding were resolved by 
the steering group. Questions which did not fit our scope, 
or could not be answered by research, were classed as ‘out 
of scope’ (see box 1 for categories used for out of scope 
questions).
Identifying out of scope questions was an iterative 
process, checked and agreed by the steering group. Over 
two meetings, steering group members were split into 
small groups and allocated questions within CSO themes 
depending on their expertise. Similar questions were 
merged and reworded into Population, Intervention, 
Comparison, Outcome (PICO) format.
Evidence searching
A data assessment group consisting of steering group 
members including young people and experts in 
evidence synthesis oversaw the evidence searches. The 
search strategy is available at: http://www. jla. nihr. ac. uk/ 
priority- setting- partnerships/ teenage- and- young- adult- 
cancer/. Searches were undertaken to identify questions 
answered by existing evidence. Searches were conducted 
during August/September 2017 and, following the JLA 
Guidebook, were restricted to the last 5 years (2012). 
Publications were relevant if they brought evidence from 
multiple studies together, for example, systematic reviews 
and qualitative meta-synthesis or were based on large, 
nationally representative cohort studies. As evidence 
was unlikely to be specific to our cohort of 13–24 years, 
evidence including older and younger populations was 
considered and the data assessment group/steering 
group debated whether further work focussing specif-
ically on the age of our cohort was required. Searches 
were also conducted for ongoing studies through clin-
ical trial databases and personal communication with 
experts.
Stage 3: question prioritisation
Interim survey preparation
Following the steps of the JLA Guidebook, there were too 
many unanswered questions to be included in the interim 
survey. The steering group considered all questions asked 
by more than one person to be high-ranking and were 
included in the interim survey, the remaining questions 
were then rated anonymously by the steering group with the 
top 104 scoring questions included in the interim survey.
Interim survey
The wording of these questions was checked by young 
people on the steering group. The survey opened in 
November 2017 for 3 weeks, publicised as in the initial 
survey. In addition, initial survey participants who left 
contact details for future participation were emailed 
directly.
Respondents were invited to rate the 104 questions. 
The options for rating were: very low priority (score 1), 
low priority (score 2), high priority (score 3), very high 
priority (score 4), no opinion (no score). Respondents 
were asked to select ‘no opinion’ if they were unsure 
about a question’s priority or had no opinion. Questions 
were grouped into sections:
1. Causes of cancer, prevention and diagnosis.
2. Treatments/therapies.
3. Short/long-term side effects.
4. Information/support.
5. Psychological support.
6. How cancer impacts on daily life.
7. Impact of cancer on families, friends and partners.
8. End of treatment and follow-up.
9. Healthcare delivery.
10. End-of-life care.
Figure 1 Pathway of care included in the project scope.
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Survey fatigue was minimised by randomisation of 
section order.
To account for missing data, average scores for each 
question were calculated for each group: patients/
former patients, family members/friends/partners and 
professionals. The questions were then ordered from 
highest to lowest score for each group. The steering 
group reviewed ratings between groups. As the distribu-
tion of respondents from the three groups was not equal, 
a simple ranking from combined scores would exces-
sively weight professionals’ views. The average ranks 
within each groups was calculated, then combined to 
give the final rank. The top 30 questions were short-listed 
for further prioritisation.
Figure 2 Overview of the Teenage and Young Adult Cancer Priority Setting Partnership methodology and results.
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Stage 4: top 10 prioritisation
The top 10 prioritisation workshop took place in January 
2018. Young people were invited from the steering group, 
self-selected survey respondents and the BRIGHTLIGHT 
Young Advisory Panel (www.BRIGHTLIGHTSTUDY.
COM). Parents were recruited through CLIC Sargent (a 
UK charity) and self-selected survey participants. Profes-
sionals on the steering group with a patient facing role 
could participate; other professionals were identified by 
the steering group.
Prior to the workshop, participants were asked to indi-
vidually rank the 30 questions in order of their impor-
tance. The workshop was chaired by SU and supported 
by two JLA facilitators. Participants were split into three 
pre-allocated groups ensuring a balance of multidisci-
plinary professionals, young people and parents. In each 
group, participants shared their three highest and lowest 
ranking questions. Discussion followed, and the groups 
ordered the 30 questions from highest to lowest. During 
the first break, ranking of the 30 questions from the three 
groups were combined. In the following session, in new 
group compositions, the combined consensus ranking was 
the discussion starting point. Following this second round 
of discussion, the group rankings were again collated and 
all participants formed one group to debate and agree 
the top 10. Two silent observers attended each of the 
three workshops; each pair included one member of the 
co-ordinating team (FG, SA and LF). The six observers 
took notes of decision making processes during the work-
shop but did not interact with the participants in any way.
Patient and public involvement
Young people were involved as equal members of the 
steering group, directing the study, developing and 
agreeing the scope, reviewing and agreeing questions, 
and were involved in all stages of the prioritisation 
process. The surveys invited responses from patients 
and carers. Young people and parents attended the final 
prioritisation workshop alongside professionals as equal 
stakeholders.
results
Initial survey
Two hundred and ninety-two people submitted 855 ques-
tions. Respondents included 108 (36%) young people, 
101 (34%) family members/partners/friends and 83 
professionals (30%). The majority of family members/
partners/friends described themselves as parent/carer, 
(n=71; 70%), 13 (13%) as relative, 13 (13%) friends and 
four partners (4%). A range of multidisciplinary profes-
sionals responded; equal numbers of nurses and doctors 
(n=25, 30%), 24 (29%) allied health professionals and 
nine (11%) ‘other’. ‘Other' included third sector (charity 
and not for profit organisations) professionals and 
academic researchers. The cancer types experienced by 
young people responding was broadly similar to incident 
cases. Supplementary material one shows respondent 
demographics.
Three hundred and twenty-six out of scope questions 
were removed, box 1 illustrates examples. Following 
combining similar questions and applying PICO format-
ting, 208 questions remained.
Analysis of uncertainties
Seven questions were considered as already answered, 
and 16 questions were the focus of ongoing studies. For 
the majority of questions, (n=185), no reviews or ongoing 
studies were identified. Where identified reviews only 
partly answered the question, these were recorded as 
unanswered. The steering group discussed all questions 
ensuring a consensus agreement of answered/unan-
swered questions.
Interim survey
One hundred and eighty-five questions were unan-
swered. Sixty-four of these were submitted by more than 
one person and therefore included in the interim survey 
along with the top 40 questions rated by the steering 
group, resulting in 104 questions in the interim survey.
Ratings were submitted by 174 respondents: 58 
(33%) young people, 45 (26%) family members/part-
ners/friends and 71 professionals (41%). In the family 
members/partners/friends group, most were parents/
carer, (n=34, 76%), with eight (18%) relatives, three 
friends and partners (6%). See supplementary material 
two for respondent demographics. More nurses (n=27, 
38%) responded than medical doctors (n=17, 24%). 
Fourteen (20%) respondents were allied health profes-
sionals and 11 (15%) selected ‘other’ (missing data, n=2, 
3%).
box 1 Out of scope question categories and examples
1. The question did not it the scope of reducing the individual and 
societal burden of young peoples’ cancer or could not be answered 
by research.
 – ‘Can a cancer sufferer become an organ donor?’
2. It was a statement rather than question (and no speciic question 
could be identiied from the statement).
 – ‘Can the late effects Drs stop telling us how BAD outcomes are 
and focus just a little on some of the POSITIVE outcomes’.
3. The question was ambiguous, was interpreted in different ways by 
steering group members and the meaning could not be resolved 
following discussion.
 – ‘Supportive care’.
4. The focus was on research methods rather than a research topic.
 – ‘How should we collect information about the late-onset side ef-
fects of cancer treatment in Teenagers and Young Adults?’
5. The question related to a speciic person’s situation/issue.
 – ‘Who can I talk to about my worries for my child?’
6. It was a political statement.
 – ‘Should medical professionals routinely explain to patients that 
there may be more up-to-date treatments available in other 
parts of the world, which may increase the patients' chances 
of survival?’
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Workshop
Twenty-five participants attended: seven young people, 
four parents and 14 multidisciplinary professionals 
including nursing, oncology, haematology, social work, 
youth-support, psychiatry and physiotherapy. Seven 
participants were steering group members. Three young 
people and one parent sent late apologies. Supplemen-
tary material three shows schematic diagram of workshop.
top 10 prioritisation strategies
Despite working independently, the three groups applied 
similar prioritisation strategies:
(1) Including all parts of the care pathway
Groups wanted the top 10 priorities to encompass the 
cancer pathway including diagnosis, new treatments, 
end-of-treatment, support, relapse, life beyond cancer 
and end-of-life care. They also wanted to reflect the range 
of professionals and diverse experiences of young people 
and parents attending.
(2) Ensuring all themes were represented
Groups clustered questions into similar themes, such as 
support, treatment/side effects, with an aim to include 
‘themes’ across the pathway. This meant choosing one 
question from each theme, as multiple questions from 
one theme would sacrifice prioritisation of a question in 
a different area. As an example, choosing ‘What General 
Practitioner (GP) or young person strategies, such as 
awareness campaigns and education, improve early diag-
nosis for young people with suspected cancer?’ or, ‘What 
are the most effective strategies for engaging primary 
care professionals (eg, GPs) to listen to young people?’
(3) Choosing questions that could include other questions/overlap
Linked to the earlier point, the groups selected overlap-
ping questions which could be answered within other ques-
tions. For example, ‘What are the best ways of supporting 
a young person who has incurable cancer?’ could include 
questions, ‘For young people with incurable cancer, 
how should parents/carers communicate with them to 
improve quality of life and experience?’ and ‘For young 
people with incurable cancer, how should healthcare 
professionals communicate with them to improve quality 
of life and patient experience?’ as communication could 
be considered within ‘support’.
(4) Considering impact and generalisability of questions
Prior to the workshop, participants prioritised their top 
3 questions based on personal experience or work area. 
However, during the workshop, participants were observed 
to reflect on their opinions and a consensus emerged that 
the top 10 should be wide reaching and avoid focusing 
on single cancers or treatments. For example, there was 
consensus on prioritisation of side-effects and ‘What 
interventions, including self-care, can reduce or reverse 
adverse short-term and long-term effects of cancer treat-
ment?’ was selected over questions which focused on one 
side-effect or treatment such as ‘What are the long-term 
physical effects of stem cell transplants, how long do they 
last and how could they be reduced?’.
(5) Questions which focus on support for families
Including a question on family support was considered a 
priority and it was agreed the question, ‘What psycholog-
ical support package improves psychological well-being, 
social functioning and mental health during and after 
treatment?’ should include supporting families.
(6) Prioritising interventions over descriptive questions
The groups were united in their view of the utility of 
descriptive studies and prioritised interventions, for 
example, ‘What psychological support package improves 
psychological well-being, social functioning and mental 
health during and after treatment?’ was prioritised over 
‘How common is psychological distress and/or mental 
health problems in young people following treatment?’, 
stating that the latter question would naturally be 
addressed by the processes involved in developing the 
intervention.
(7) Excluding questions considered to be too subjective to be 
answered by research
Some questions were considered too individual and/or 
subjective to address. For example, ‘What are the factors 
that should determine stopping treatment when the 
young person cannot be cured?’, participants agreed this 
was person-dependant and too variable to generate a ‘tick 
list’ of factors which would determine stopping treatment. 
Similarly, within the same theme, ‘For young people with 
incurable cancer, how should healthcare professionals 
communicate with them to improve quality of life and 
patient experience?’ was considered to be subjective, with 
participants agreeing its importance but also a difficult 
skill to teach to professionals and was manifestation of a 
wider social problem of our views on death and dying.
The final group exercise generated considered debate 
around the order of questions, and terminology, however 
the top 3, remained consistent after the first part of the 
workshop. Of note, a number of questions underwent 
slight wording changes; at the request of young people 
‘self-care’ was included as an intervention for priority 
number 2 and the word ‘normal’ was removed from one 
of the questions in the remaining top 20. Healthcare 
professionals requested, ‘specialist care’ be replaced with 
‘Principal Treatment Centre’ in question 6. The final 
agreed, top 10 priorities for young people with cancer are 
shown in box 2 and box 3 lists the remaining 20 ques-
tions discussed at the workshop but not placed in order 
of priority.
DIsCussIOn
The Teenage and Young Adult Cancer PSP has brought 
together for the first time, young people, carers and 
professionals to prioritise research questions focused on 
young people with cancer. The top 10 priorities provide 
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a much-needed resource to inform research funding 
decisions in government and charitable agencies. The 
priorities highlight the need for research strategies to be 
holistic in their approach rather than driven by biological 
and drug intervention research. The top research priority 
was identified as, ‘What psychological support package 
improves psychological well-being, social functioning 
and mental health during and after treatment?’ The 
top 10 priorities include the complete cancer ‘timeline’: 
finding biological targets; early diagnosis; access to new 
treatments; supporting families; returning to education/
employment; minimising the long-term effects of treat-
ment; supporting young people whose cancer cannot 
be cured; and supporting bereaved families and carers. 
While the majority of questions are related to the health-
care setting, the breadth of the questions and those in 
the remaining 20 include communication; relationships; 
service provision; social and educational milestones, thus 
suggesting that research funding could also be sought 
from social and educational funding bodies. It is now 
critical that funders and researchers ensure that future 
research focuses on what is important to young people, 
carers and professionals.
In a previous consultation exercise in which young 
people rated research topics already identified by profes-
sionals, improving time to diagnosis was prioritised as the 
most important area of research, followed by late-effects 
and survivorship.12 Quality-of-life was rated as important 
as survival by 75% of the young people participating and 
they also wanted research to include the effect of cancer 
on family and friends.12 These priorities are all reflected 
in the top 10.
The top priority identified in this exercise reflects an 
increasing drive to focus on both physical and psycho-
logical health during and after cancer.18 It is increasingly 
recognised that a cancer diagnosis has serious implications 
box 2 top 10 research priorities for teenage and young 
adult cancer
1. What psychological support package improves psychological 
well-being, social functioning and mental health during and after 
treatment?
2. What interventions, including self-care, can reduce or reverse ad-
verse short-term and long-term effects of cancer treatment?
3. What are the best strategies to improve access to clinical trials?
4. What General Practitioner or young person strategies, such as 
awareness campaigns and education, improve early diagnosis for 
young people with suspected cancer?
5. What are the best ways of supporting a young person who has 
incurable cancer?
6. What are the most effective strategies to ensure that young people 
who are treated outside of a young person’s principal treatment 
centre receive appropriate practical and emotional support?
7. What interventions are most effective in supporting young people 
when returning to education or work?
8. How can parents/carers/siblings/partners be best supported fol-
lowing the death of a young person with cancer?
9. What is the best method of follow-up and timing which causes 
the least psychological and physical harm, while ensuring relapse/
complications are detected early?
10. What targeted treatments are effective and have fewer short-term 
and long-term side-effects?
box 3 the additional 20 questions taken to the workshop 
(not listed in order of priority)
Diagnosis
 Ź What factors affect the time to diagnosis and what outcomes are 
affected?
 Ź What are the most effective strategies for engaging primary care 
professionals (eg, general practitioners) to listen to young people?
treatment
 Ź What key factors (both cancer and individual) determine whether 
a treatment plan for children or adults will give better outcomes?
 Ź What is the best treatment for brain cancers to increase survival and 
decrease toxicity?
 Ź What are the factors that predict life threatening chemotherapy side 
effects?
After treatment
 Ź What can young people do to help their recovery after chemotherapy 
or radiotherapy?
 Ź What are the long term physical effects of a cancer diagnosis and 
treatment and how long do they last?
 Ź What are the long-term physical effects of stem cell transplants, 
how long do they last and how could they be reduced?
 Ź How common is psychological distress and/or mental health prob-
lems in young people following treatment?
 Ź What causes problems with cognitive functioning (‘chemobrain’), 
how long do they last and what are the most effective treatments 
and strategies?
 Ź At the end of treatment and during long term follow up, what sup-
port services improve psychological well-being, social functioning 
BOENFOUBMIFBMUI t
 Ź What are the best ways to support young people getting back to 
‘everyday’ life after treatment?
 Ź What interventions are most effective in supporting young people 
who are experiencing fatigue/tiredness when returning to work or 
education?
 Ź What are the best strategies for detecting and treating second pri-
mary cancers early?
relapse
 Ź What is the most effective way of supporting young people with 
relapsed cancer?
end of life
 Ź What are the factors that should determine stopping treatment 
when the young person cannot be cured?
 Ź For young people with incurable cancer, what methods, techniques 
or strategies for communication can help them to talk with their 
family and friends about their situation?
 Ź For young people with incurable cancer, how should healthcare pro-
fessionals communicate with them to improve quality of life and 
patient experience?
 Ź For young people with incurable cancer, how should parents/carers 
communicate with them to improve quality of life and experience?
 Ź What are the support needs of the family following the death of a 
young person with cancer? The remaining 20 priorities discussed 
at the workshop
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for young people’s mental health but this has yet to be 
systematically investigated; a recent UK survey reported 
79% of young people felt cancer seriously impacted their 
emotional well-being, 70% of young people reported 
depression during treatment and 90% experienced 
anxiety during treatment.19 How these young people are 
best supported is currently unknown.
A number of cancer-related PSPs exist, however, this is 
the first PSP to focus on an ‘age’ rather than a ‘cancer 
type’ and the whole cancer pathway. The recent Living 
with and Beyond Cancer PSP reflects similar priorities as 
the Teenage and Young Adult Cancer PSP highlighting 
the need to have a holistic approach to research under-
taken, that focusses on psychological impact, under-
standing and managing side-effects, and information that 
helps those with cancer to make life-style choices that 
help them to live their lives fully (https://www. ncri. org. 
uk/ lwbc/).
Challenges, strengths and limitations
We encountered several challenges. Our time to 
complete was 3 years versus an anticipated 12–18 months. 
The appointment of a dedicated researcher who also 
administered steering group meetings, agendas, minutes 
and travel arrangements was critical to the project’s 
final completion. The project was resource intensive, 
requiring input from all steering group members. This 
was challenging when involving clinicians with full sched-
ules, and young people in full-time employment/educa-
tion. Further to this, the scope of the PSP was kept broad 
to reflect the diverse care pathways and needs of young 
people with cancer and we also considered questions 
relating to families and extended networks whereas other 
PSPs have excluded questions which are not patient-fo-
cused.20 The wide scope generated increased work for 
sorting and handling more diverse questions which often 
did not neatly fit the ‘PICO’ format recommended by the 
JLA.
The use of the rigorous and transparent JLA method 
enhances the validity of the process and results. It is 
notable that the proportion of respondents from each 
of the three groups (young people, carers and profes-
sionals) submitting questions was about the same, and 
similar themes from their questions was reflected across 
these groups. Young people were involved in shaping 
the project from the outset, as members of the steering 
group. Their input was key; for example, they helped 
to ensure the surveys were presented in a user-friendly 
format and appropriate routes to dissemination were 
used. Young people all reported a positive experience of 
being involved in the steering group,
If you have been affected by cancer, whether that’s as 
a young person or have been involved in their care 
as a parent, carer or professional, you will know that 
there are a lot of unanswered questions. As a survivor, 
my main priority is around long-term effects from 
cancer treatment and I’m glad that this question 
made it in the Top 10. It has been a privilege to be 
involved in this project, I’m looking forward to seeing 
change within the young people’s services whether 
that’s at the point of diagnosis, during treatment or 
survivorship." Comment from young person on steer-
ing group
Further to this, we know that the acceptability of 
research questions influences professionals’ decisions to 
offer study entry and young person’s likelihood to enrol 
in a study8; we have a collective list of research questions 
‘acceptable’ to both professionals and young people.
Despite the projects’ strengths, we acknowledge 
limitations. We do not know the response rate of survey 
uptake given the snowballing method of recruitment. 
The majority of young people and carers were white and 
female. This was in spite of targeting charities and user 
groups which focus on males and minority groups. This 
is typical with survey research and many other PSPs have 
reported a low proportion of responses from males and 
people from a range of ethnicities.21 22 Further research 
could explore interventions to encourage the partici-
pation of these groups in such surveys to maximise the 
chance of the voices of these under-represented cohorts 
being heard. We also did not explore gender orienta-
tion beyond ‘male/female/other/prefer not to answer’ 
during data collection or in the workshop. On searching 
the internet young people on the PSP identified 75 
terms for gender, it was their suggestion that to reduce 
discrimination we should leave an option 'other' with free 
text option. ‘. However questions related to lesbian, gay, 
bisexual and transgender young people were submitted 
and can be viewed in the full report. We would encourage 
researchers to include the needs of these groups during 
protocol development and in designing recruitment strat-
egies. Very few young people currently on treatment took 
part; however, we know from other research that during the 
treatment phase young people will approach their treat-
ment team for answers to questions and it is when nearing 
the end of treatment that young people start to consider 
additional questions.23 Similar to other PSPs involving 
children and young people,20 the younger end of our 
cohort were less well represented (aged 13–15 years) and 
future PSPs involving young people may need to consider 
alternative data collection methods for this group.
IMPlICAtIOns
The uncertainties raised and prioritised are the outcome 
of a systematic and transparent process with stakeholders 
who have not often had a voice in setting the research 
agenda. When selecting the questions to be included in 
the top 10, the workshop participants intentionally opted 
for broad questions, in order to capture the wide range of 
issues. For some questions, further refinement is required 
to take the topic forward as a feasible research project. 
Many questions encompass a range of interventions 
requiring a programmatic approach to research reflecting 
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growth of the community and are ideally placed for major 
research funding calls.24 For these, specific interventions, 
comparators and outcomes require identification along 
with decisions made about how and when outcomes are 
measured.
Many questions submitted in the survey were consid-
ered to be outside the scope of this initiative. Examples 
include queries about availability of services or informa-
tion, questions about research methodology and personal 
questions relating to someone’s particular situation. The 
steering group considered these questions to be important 
and were determined to ensure these submissions were 
not ‘lost’. Further analysis of these out of scope questions 
is under way as they highlight gaps in information provi-
sion indicating that better signposting for young people 
and families is required.
COnClusIOn
For too long now, the research funding landscape has 
overlooked young people with cancer, prioritising 
research in the main cancer types occurring in adults. 
Our community is further disadvantaged by the absence 
of young person specific research funding bodies. Despite 
these real challenges, we now have available for funders, 
researchers, clinicians and the wider community, system-
atic evidence of the priority areas of research, confirmed 
as unanswered and defined as important by young 
people, their networks and the healthcare professionals 
caring for them. In the UK, other PSPs have generated 
themed calls from major funders.25 As a community, we 
eagerly await the response of these same institutions to 
the identified research priorities in this typically under-
served population.
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